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Abstract

The aim of this research was to evaluate the mechanical properties, biocompatibility, and degradation
behavior of scaffolds made of pure hydroxyapatite (HA) and HA‐modified by MnO2 for bone tissue
engineering applications. HA and MnO2 were developed using sol‐gel and precipitation methods,
respectively. The scaffolds properties were characterized using X‐ray diffraction (XRD), Fourier
transform spectroscopy (FTIR), scanning electron microcopy (SEM), energy dispersive spectroscopy
(EDS), and transmission electron microscopy (TEM). The interaction of scaffold with cells was assessed
using in vitro cell proliferation and alkaline phosphatase (ALP) assays. The obtained results indicate
that the HA/ MnO2 scaffolds possess higher compressive strength, toughness, hardness, and density
when compared to the pure HA scaffolds. After immersing the scaffold in the SBF solution, more
deposited apatite appeared on the HA/MnO2, which results in the rougher surface on this scaffold
compared to the pure HA scaffold. Finally, the in vitro biological analysis using human osteoblast cells
reveals that scaffolds are biocompatible with adequate ALP activity. [ABSTRACT FROM AUTHOR]
Keywords: biocompatibility; cold isostatic pressing; mechanical properties; nanocomposite

INTRODUCTION

The bone is the main organ of the skeletal body, which supports soft tissues and includes the bone
marrow that is the site of the formation of blood cells.1 When a bone breaks, bone fields are destroyed
and the damaged area around the bone cells die. In many fractures and bone injuries, there is a need
for alternative or filler materials to repair bone tissue.2,3 So far, various engineering materials, including
ceramic materials, metals (alloys), polymers, and composites, have been selected as bone tissue
repairers. The bulk of the bone tissue is composed of hydroxyapatite (HA) bioceramic with the
chemical formula Ca10(PO4)6(OH)2, which is a mineral component of bone with low crystallinity HA and
has strengthened its collagen fibers.4,5 Two‐phase calcium phosphate ceramics are a mixture of two
phases of HA and beta‐tri calcium phosphate, which are commonly used in bone repair. By changing
the ratio of HA to beta‐tricalcium phosphate, it is possible to control the bioactivity of these types of
ceramics. Changing this ratio changes the chemical properties of this substance.6 HA is used for bone
tissue engineering due to its excellent biocompatibility and bone mineralization, bioactivity, non‐
toxicity and non‐inflammation and immunology in bone tissue engineering.7‐9 Although the elasticity
modulus of HA is higher than the bone, it alone does not have the mechanical properties of the bone.
HA has an inherently fragile structure, which limits its application to areas of the body that are under
high loads. Many studies have been done to improve the mechanical properties of HA. One way to
overcome this limitation is to use HA as a matrix in a composite and to use biocompatible or bioactive
reinforced materials. Therefore, the reinforcement materials in HA matrix are chosen in such a way
that their final modulus of elasticity is as close as possible to the bone elastic modulus.10,11

Manganese dioxide (MnO2) has excellent performance in terms of availability, economic efficiency,
nontoxicity,12,13 biocompatibility14,15 and is environmentally friendly.16 The structure of MnO2 is micro‐
porous.17 Correction of the particle surface of the HA with MnO2 reduces the temperature of the
sintering, thereby increasing the density of HA. Bones and teeth have about a total of 20 mg of
Manganese. Manganese in the bone reduces bone resorption and also plays an important role in
immune response, homeostasis of glucose, ATP regulation, reproduction, digestion, and bone growth,
and has a significant effect on bone growth. Therefore, the placement of manganese compounds along
with the structure of apatite is of great importance, since the behavior and properties of HA are more
similar to bone. Manganese also activates the function of the formation of cartilage in bone and skin
and synthesis of various enzymes for bone formation.18‐20 Manganese also has antioxidant activities.22
Studies have shown that HA doped with Mn promotes osteoblast proliferation and activates their
metabolism and differentiation.22 In this study, HA was synthesized by sol‐gel method. In fact, sol‐gel is
the most commonly used method for the production of nanoparticles in the liquid phase due to the
lack of special equipment and the ease of process steps, the acceleration of bone treatment and the
reduction of bio‐contamination.22
The cold isostatic pressing (CIP) method is applied in such a way that the pressure is applied
simultaneously and uniformly from all directions while all the friction of the sample with the mold wall
is completely eliminated. To compress simple or even relatively complex shapes by this method, the
dry powders are poured into a flexible metal mold and filled. Then, by pressing the die piston, the
sample is formed into a disk or cylinder, enclosed in latex, and thrown into the CIP oil tank. Inside the
tank, the latex content of the sample is completely surrounded by hydraulic fluid. After applying
pressure, the sample is removed from the machine. This sample does not have enough cohesion and
must be sintered. Typically, the pressures in CIP can be ~70 MPa, although pressures > 100 MPa to
~400 MPa are often used. The most important characteristics of pressed ceramic bodies produced by
CIP method include dimensional accuracy, robustness and high density. High production speed and
cost savings have made it widely used in the ceramic industry.23,24 For this reason, CIP method was
used to prepare the scaffold in this study.
This study intends to modify the HA nanoparticles with MnO2 nanoparticle precipitation. To construct
the scaffolds, the CIP was used, and then the samples were sintered at 1300°C. Microstructure,
biodegradability, biocompatibility, and mechanical properties of scaffolds were then investigated.

MATERIALS AND METHODS
Material preparation
HA synthesis
Nano‐HA was prepared by sol‐gel method, as described previously.25 Briefly, Ca(NO3)2.4H2O (0.1 M,
Sigma‐Aldrich) and (NH4)2HPO4 (0.06 M, Sigma‐Aldrich) were dissolved in deionized water separately,
and the pH of both solutions was adjusted to 11.0 by adding ammonia solution. The solution of
Ca(NO3)2.4H2O was dropwise added into the (NH4)2HPO4 solution for 1 hour, and the white suspension
and gelatinous precipitate were obtained. After aging for 24 hours at room temperature, the
precipitates were filtered, washed several times with distilled water and absolute ethanol, dried at
80°C overnight, then calcined at 800°C for 1 hour.

Preparation of MnO 2 ‐modified‐HA powder
250 cc KMnO4 (0.02 M, Sigma‐Aldrich) solution was prepared and nano‐HA (2 g) was then added into
the solution, followed by constant stirring for 2 hours at room temperature. Then, solution was
sonicated for 20 minutes and after that stirred for 72 hours again. Finally, the brown precipitates were
washed with deionized water and ethanol and dried at 80°C overnight. The obtained powder was
calcined at 400°C for 5 hours.26
Preparation of MnO 2 modified‐HA scaffolds
The prepared MnO2 modified‐HA powder was CIP at 250 MPa for 35 seconds. Samples of various tests
were made in two forms of disk and cylinder with CIP device. The pressed powder was then sintered at
1300°C for 2.5 hours in a box furnace at a heating rate of 5°C/min. Next, the samples in the shape of
circular discs were produced for hardness or compression tests. Figure 1 shows prepared samples for
hardness and compressive tests.

1 Prepared samples for compressive and hardness tests

Material characterization

To investigate the phase composition of extracted HA powder, XRD: (Bruker‐AXS‐D8‐Discover) analysis
was carried out before and after sintering the HA. The XRD system works with voltage and current
setting of 40 kV and 40 mA, respectively, with parallel graphite monochromator and uses CuKα
radiation (1.5406 Å). For qualitative analysis, XRD diagrams were recorded in the interval 20‐65°, with a
step size of 0.02°.
To identify the existence of organic species, along with the degree of probable dehydroxylation of HA
during the heat treatment, Fourier transform infrared (FTIR: Shimadzu 8300) analysis was performed.
The measurements were carried out in the transmission mode in the mid‐infrared range with wave
numbers from 400 to 4000 cm−1. To record the FTIR spectrum of each sample, 3 mg of the powder was
mixed and pressed with 300 mg of KBr to obtain a pellet for FTIR analysis.
A scanning electron microscope (SEM) equipped with energy dispersive spectroscopy (EDS) was used
to examine the morphology of the powder and scaffolds. The porosity of scaffolds was also
investigated by SEM.
A transmission electron microscope (JEOL JEM‐2100 TEM) was used to assess the nanoparticles'
morphology and size in the MnO2 modified HA scaffolds.
The XRD chart was plotted by Xpert software. Spectra from FT‐IR analysis were plotted by Spectra
Analysis software. Stress‐strain diagrams derived from pressure test, thermal gravimetric analysis‐

differential scanning calorimetry (TGA‐DSC) diagram and cell culture diagrams were plotted by
origin.2018 software.

Mechanical properties

Mechanical properties of the samples were evaluated with compressive and hardness tests. The
compressive test was performed on cylindrical samples (10 mm in diameter × 10 mm in length) using a
universal testing machine (Zwick, Material Prufung, 1446e60) with a 10 kN load cell. Although the best
sample for compression test is a diameter‐to‐height ratio of 1/2, in the ceramic samples, we can also
test the compression with a diameter‐to‐height ratio of 1.27 The crosshead speed was 0.5 mm/min.
The surface area under the stress‐strain curves was calculated and considered as the toughness of the
samples. Disc shape samples were selected for microhardness test (16 mm diameter × 4 mm height).
The microhardness (Hv) of the polished sintered samples was determined via the Vickers indentation
(MHV1000Z) using an applied load of 200 g with a dwell time of 10 seconds. The density of samples
was measured by Archimedes method.

In vitro biodegradability

The sintered HA samples were soaked in 20 mL of simulated body fluid (SBF) with pH 7.40 and specific
ion concentrations nearly identical to those in human blood plasma (Na+ 140.3 mm, K+ 5.3 mm,
Mg2+ 1.3 mm, Ca2+ 2.2 mm, Cl− 148.0 mm, HCO3− 4.0 mm, HPO42− 0.8 mm, SO42− 0.5 mm). After the
samples were kept at 37°C for 28 days, they were removed from SBF, gently rinsed with distilled water
and dried at room temperature. The changes in the surface morphologies of samples before and after
soaking in the SBF were characterized by SEM and EDX.

Cell culture

To sterilize the samples, they were immersed in 70% ethanol three times, followed by washing with
phosphate buffer saline (PBS) for 15 min/cycle. The culture medium was prepared from Dulbecco's
Modified Eagle's Medium (DMEM, Sigma) supplemented with 10% fetal bovine serum (FBS, Sigma) and
1% Penicillin‐Streptomycin (Invitrogen). 5 × 105 Human Osteoblast Cells (HOB, Cell Applications) were
cultured on the samples immersed in growth medium. The medium was refreshed every 2 days.
The morphology of HOB cells cultured on the samples was studied by scanning electron microscopy
(SEM, JEOL JSM‐6510LV) after 14 days' culture. To prepare the samples for SEM imaging, they were
removed from the culture medium, rinsed in PBS and cells were fixed with 10% formaldehyde solution.
The samples were then dehydrated in gradient ethanol concentrations of 50, 70, 80, 90, and 100% to
protect their intact morphology. The samples were coated with gold using a GSL‐1100X‐SPC12
Compact Plasma Sputtering Coater instrument, prior to SEM imaging. ProstoBlue® (PB) cell vitality
(Invitrogen) was performed according to the manufacturer's protocols at time intervals of 7 and
14 days after cell seeding. The samples were sterilized using 70% ethanol. The samples were then
placed in a non‐adherent 24 well‐plate and 5 × 105 HOB cells were seeded on the samples. The culture
medium was changed every 2 days.
The fluorescence intensity (Ex: 560 nm and Em: 590 nm) was measured by a spectrophotometric plate
reader (Synergy HTX, BioTEK). Triplicate samples were used for this experiment.

Alkaline phosphatase activity

Alkaline phosphatase activity (ALP) of HOB seeded samples was performed using an ALP assay kit
(Abcam) after 14 days. The seeded cells on the samples were lysed with RIPA lysis and extraction buffer
(Invitrogen). Fifty microliter of lysate was reacted with 150 μL of p‐nitrophenyl phosphate (p‐NPP) for
45 minutes at 37°C. The reaction was terminated with stop solution, and the absorbance intensity of p‐
nitrophenol was determined at 405 nm, using a microplate reader (Synergy HTX, BioTEK). Cell lysates
were investigated for protein content using a micro‐BCA assay kit (Pierce), and ALP was normalized to
the total protein content, which was measured using Pierce BCA protein assay kit. ALP was expressed
in arbitrary units. Triplicate samples were used for this experiment. All data was shown as
mean ± standard deviation (mean ± SD). The significant difference was analyzed by one‐way ANOVA
complemented by Tukey's multiple comparisons test. P < .05 were considered as statistically
significant.

RESULTS AND DISCUSSION
XRD analysis

Figure 2A,B show the XRD analysis for pure HA and HA/MnO2. The XRD pattern of these samples shows
the following broad diffraction peaks at 26.172, 28.25, 29.1, 31.9, 32.35, 33, 34.2, 39.96, 46.85, 48.25,
50.65, 51.4, 52.35, 63.1, and 53.38° (Figure 2A). All reflections are characteristics of the hexagonal
phase of HA [Ca10(PO4)6(OH)2], according to the standard data (JCPDS No. 01‐074‐0566).28 The
obtained patterns are in agreement with Kim et al29 and Heidari et al.30,31 MnO2 peaks were also
seen at angles of 18.20, 28.88, 35.46, 37.5, 41.97, 49.39, and 60.3°.26,32 Given that the intensity of the
peaks of the pattern of Figure 2B is greater than that of Figure 2A, it is concluded that the HA
crystallinity increased by adding MnO2. Additionally, the additional phase of tricalcium phosphate (TCP)
in the HA powder was detected at the angles indicated in the pattern of Figure 2A,B (rhombuses on the
graph). These peaks, which represent β‐TCP, decreased with the addition of MnO2. The study of the
effect of calcination on HA powder showed that β‐TCP peak at 800°C began to emerge. The decrease of
the β‐TCP peak with the precipitation of MnO2 may be due to the replacement of the Mn ions with Ca
ions in the β‐TCP phase. The twin Mn ions seem to partially occupy Ca2+ sites in the β‐TCP structure.
Therefore, due to the larger atomic radius Mn than Ca, the intensity of the β‐TCP peak is reduced by
this replacement.19 The absence of any peak at 37.5°, indicating CaO, can be due to stoichiometry with
a ratio of 1.67 and its conversion to HA. By adding MnO2 to HA, a distinct color change was observed
from white to cream. However, after sintering in the air at 1300°C, the pure HA remained white, while
the HA containing MnO2 changed from cream to blue (Figure 1).

2 XRD pattern of (A) pure HA, (B) HA/MnO2 composite

FTIR analysis

The stretching band at 3426.89 cm−1 and liberation band at 632.537 cm−1 originate from OH− groups.
The bands located at 472.474, 568.798, 601.682, 1039.44 and 1091.51 cm−1 originate from PO43‐ ions,
and are weaker than the strong P‐O stretching vibration due to HA stoichiometry. The bands at
1400.07 and 1614.13 cm−1 originate from CO32− ions (Figure 3A). Carbonate ions are a common
impurity in both synthetic and natural HA.27 The FTIR spectrum of the sample that was heat treated at
800°C is in good agreement with the spectrum reported by Heidari et al27 for natural HA material (see
Figure 3A). The peak observed at 580‐560 cm−1 is related to the vibrational state of Mn‐O and confirms
the oxidation of Mn19,33‐36 (Figure 3B).

3 FTIR analysis of (A) HA, (B) HA/MnO2 powder

Scanning electron microscope images

Figure 4A,B show the SEM images of the cross‐sectional area of the pure HA and HA/MnO2 composite
samples sintered at a temperature of 1300°C. Results show that modification of HA with MnO2 reduces
the porosity of HA (Figure 4A) and enhances its sinterability (Figure 4B). Royer et al37 and Wang et al38
reported that HA degradation began at about 1300°C. In general, sintering HA can result in partial
thermal decomposition of HA to TCP or tetra‐tricalcium phosphate(TTCP). Thermal decomposition
consists of two steps: dehydroxylation and decomposition. Dehydroxylation to oxi‐HA at a temperature
of about 850‐900°C with a completely reversible reaction is performed as follows:
Ca10 (PO4 )6 OH2 → Ca10 (PO4 )6 OH2−2X OX + xH2 Ogas .

4 SEM images of (A) HA scaffold (cross‐sectional view) and (B) HA/MnO2 scaffold (cross‐sectional view)

HA was decomposed to TCP or TTCP with the following reaction at temperatures above 900°C:
Ca10 (PO4 )6 OH2 → 2Ca3 (PO4 )2 + Ca4 P2 O9 + H2 Ogas .

In Figure 4A, porosity formation can be due to dehydroxylation within the HA matrix. Dehydroxylation
is achieved by releasing OH ions in a wide range of temperatures, and it is reported to depend on
partial pressure of H2O during heating. Thus, for HA, slight dehydroxylation can occur. With further
increase in temperature, HA dehydration may continue, resulting in the formation of internal vapor
pressure in closed vents near the free surface of the HA sample. In Figure 4B, when the MnO2 powder
is precipitated on the HA, the particle fusion is increased. In this way, there is very low porosity in the
HA/MnO2 sample. In short, MnO2 helps sintering of two‐phase calcium phosphate. This can be applied
to the use of two‐phase calcium phosphate powders for bone implantation, because denser implants
have better mechanical strength.19,39

TEM images

The morphology of pure HA and HA/MnO2 powders was investigated by TEM (Figure 5A,B). It is
observed that particles have a spherical shape. HA spherical particles have dimensions less than
100 nm (Figure 5A). Figure 5B also shows the white precipitates on these particles that are less than
10 nm and are indicated by an arrow on the Figure 5B.

5 TEM image of HA/MnO2 powder

TG/DTA analysis

Figure 6 shows the weight loss of total water present in the crystalline HA network, a reduction in the
weight associated with the HA mineral composition analysis is also shown. The full graph (TGA)

represents three almost linear regions: the temperature ranges of 100‐400°C and 600‐800°C, with a
low dehydroxylation rate and a temperature range of 800‐900°C, with high dehydroxylation rates. The
kinetics indicate that dehydroxylation generally occurs at high temperatures, but 800°C is a reasonable
amount for assigning a small amount of dehydroxylation rate.40 This is in agreement with the research
by Santos et al.41 The TGA chart consists of three steps: from ambient temperature up to 200°C, 400‐
600°C, and 800‐900°C. The first step is the evaporation of moisture, the oxidation of sediment solvents,
and pre‐mineral decomposition at a temperature of 200°C. Extensive endothermic peak was observed
in the DSC curve (Figure 6) at about 50°C, which was attributed to water loss. The dashed line graph
(DSC) has an exothermic peak in this temperature range, which indicates the evaporation process. In
the first step, the HA/MnO2 mass is slowly decreased by 0.2%, which is related to the removal of water
absorbed on the composite surface and the loss of water in the network.26 In the second step, a weight
loss of up to 1% is observed, which is related to the decomposition of the mineral compounds
associated with HA. In the third step, a significant drop in weight of 0.5% was observed at temperature
above 800°C, indicating that the synthesized HA was heated to higher temperatures at 800°C and then
decomposed into secondary phases such as TCP, and the processed product will be two‐phase calcium
Phosphate. The dashed line graph has an exothermic peak (DSC analysis in Figure 6) in this
temperature range, which illustrates this process.

6 TG/DSC analysis of HA/MnO2 composite powder

Mechanical testing

Heidari et al reported that HA samples extracted from the cattle bone—pressed with a CIP method and
sintered at 1300°C—have a compressive strength of 3.25 MPa and a toughness of 0.3 MPa.27 However,
in this study, with the same manufacturing conditions, the compressive strength of the pure HA sample
obtained is 13.02 MPa, while the toughness is reduced to 0.14 MPa (Table 1). Furthermore, hardness in
these specimens has been shown to increase by 0.6 GPa than those made from natural HA. These
changes are likely due to the HA powder, which had been synthesized by the sol‐gel method, and the
size of the powder was smaller compared to HA used in our previous study.27 Addition of MnO2 to HA
results in an increase in hardness (from 3.9 to 4.8 GPa), an increase in density (from 2.83 to 2.97 g/cm3)
which SEM images also confirm (Figure 4), an increase in compressive strength (from 13.02 to
13.87 MPa), and an increase the toughness (from 0.14 to 0.28 MPa) of the samples (P ˂ .05). Hence,
our results show that MnO2 increases the fracture energy of the samples due to the condensation of

the samples under the same conditions of production. The percentage of increase in compressive
strength of pure HA to MnO2/HA was 6.5%. This increase in compressive strength was also predictable
with SEM images (Figure 4) as the porosity of pure HA scaffold decreased with the addition of MnO2.
Bone compressive strength is 2‐10 MPa.42,43 Therefore, in this study, both pure HA and MnO2/HA
scaffolds have higher compressive strength than bone, so the toughness of each one is important. The
MnO2/HA toughness is twice that of pure HA, which means that the energy absorption up to the
fracture of the MnO2/HA scaffolds is greater than that of pure HA. Also, the origin of the blue HA after
the precipitation of MnO2 and sintering at 1300°C is due to the presence of Mn5+ or MnO43− ions in
PO43− sites in the crystalline apatite structure. According to authors, high temperatures not only
increase the oxidation intensity in the oxidizing atmosphere, but also provide enough energy for
oxidized Mn ions to facilitate their migration to the crystal network. This color change caused by ions
migration has a good effect on increasing the mechanical properties of the HA/MnO2 composite.39
Ramesh et al39 showed that the addition of 0.05% Manganese oxide to HA with a sintering
temperature of 1100‐1000°C leads to an increase in the hardness of HA, especially for samples that are
sintered at temperatures below 1000°C. It was therefore predictable that the surface modification of
the HA powder with MnO2 would increase its hardness.
1 TABLE. Mechanical properties of HA and MnO2 ‐modified HA scaffolds
Compressive strength (MPa) Toughness (MPa) Hardness (GPa) Density (g/cm3)
HA
13.02 ± 0.15
0.14 ± 0.03
3.9 ± 0.1
2.83
HA/MnO2 13.87 ± 0.17
0.28 ± 0.05
4.8 ± 0.1
2.97
Figure 7A,B show compressive stress‐strain diagrams for scaffolds. It can be seen that in each chart, the
stress has been steadily increasing, and this ascending trend continues so that samples cannot
withstand the stress, and crack. After cracking the samples, there is a sharp drop in the stress.
Maximum compressive strength is considered at the point where stress begins to decrease. Figure 7
shows that with the deposition of MnO2 on HA, the compressive strength of composite samples is
increased in comparison to pure HA, which is due to the high strength of MnO2 compared to the HA in
the composite.44

7 Compressive stress‐strain curve of pure HA and HA/MnO2 scaffolds

Immersion in SBF solution

Figure 8a‐c indicates the SEM images of HA and HA/MnO2 after 28 days immersion in SBF. Figure 8A,B
show that apatite deposition on pure HA is completely uniform, but Figure 8C indicates the increase in
the surface roughness of HA/MnO2.

8 SEM images from the surface of the scaffold after 28 days of immersion in SBF solution, (A) pure HA, (B) HA
with higher magnification, (C) HA/MnO2, (D) EDAX analysis of the deposited layer on the surface of HA/MnO2
scaffold

The formed apatite has been further analyzed and confirmed by EDAX, showing the main elements are
calcium and phosphorus (Figure 8D). Also, other elements (chlorine and sodium) are detected in our
EDAX analysis, which can be due to the NaCl in the SBF solution.
The surface roughness of the HA scaffolds is shown in Figure 9A. The mean roughness of the samples
before and after immersion in SBF indicated in Table 2. Figure 9B shows the AFM graph of HA/MnO2,
when the roughness of MnO2 deposited on HA has decreased from 955.2 to 423.5 nm (Table 2).
Figure 9C shows the AFM graph of the surface of the pure HA sample after immersion. Surface
roughness decreases by 338.4 nm, compared to before immersion. Figure 9D shows the surface of the
HA/MnO2 sample. The surface roughness in this sample has increased from 423.5 to 460.4 nm
(Table 2). Our results show that MnO2 can increase apatite deposition on the surface of HA scaffolds.
Usually at roughness more than 50 nm, van der Waals forces are the main factor; while at closer
distances (10‐20 nm), a combination of both van der Waals forces and electrostatic interactions
controls cell adhesion.45 For metals used in medical implants, the desired surface roughness is usually
below 10 nm.46 Rough surface promotes friction, thus reduces the mobility of the bacteria; this sessile
environment facilitates the biofilm growth.47 Hence, HA and HA/MnO2 have a significant surface
roughness and can be a good place for cell proliferation.

9 Analysis of surface topography using AFM from (A) surface of pure HA scaffold before immersion, (B) surface
of HA/MnO2 scaffold before immersion, (C) surface of pure HA scaffold after immersion and (D) surface of
HA/MnO2 scaffold after immersion in the SBF solution

2 TABLE. Amount of roughness of surface samples
Samples
HA
HA/MnO2

Surface roughness before
immersion (nm)
995.2
423.5

Cell culture

Surface roughness after
immersion (nm)
616.8
460.4

Change in roughness
(nm)
−338.4
+36.9

ALP is believed to be upregulated in the early stages of biomineralization in order to form a large pool
of inorganic phosphate from which HA can be mineralized.48 After the onset of mineralization, ALP is
no longer needed, and therefore, cellular levels of the enzyme drop before a mature mineralized

matrix is formed.49 Figure 10 shows the results of ALP after 14 days. The average data show the activity
of ALP for pure HA is more than HA/MnO2 scaffolds.

10 ALP assessment on HA and HA/MnO2 scaffolds (14 days)

Figure 11 shows the proliferation of human osteoblast cells on the surface of the scaffold. Darker
graphs appear after 7 days, and clearer graphs after 14 days in the culture medium. Both samples show
more cell proliferation after 14 days than 7 days. Generally, the proliferation of cells on pure HA is
higher than that of HA/MnO2, but both samples show good viability after 7 days compared to the
control sample. In such conditions, we should know that at some concentrations, Mn ions could also
have negative effects on the cells.50 Lower cell proliferation of MnO2/HA is probably due to the faster
and higher ion release such as Mn from the porous scaffolds compared with the pure HA.51 Future
studies are recommended for measurement of the released Mn ion from HA/MnO2 constructs and
screening the best concentration. Furthermore, the efficacy of these samples against different bacteria
might be assessed.

11 Cell proliferation diagrams on HA and HA/MnO2 scaffolds after 7 and 14 days

Figure 12 shows SEM images of human osteoblast cells attached to the surface of the specimens after
14 days, confirming the biocompatibility of our HA and HA/MnO2 scaffolds. According to SEM
observations, the human osteoblast cells retaining spindle morphology on the scaffolds. The osteoblast
cells projections and pseudopodia were detected and, fibrous extracellular matrix (ECM) was observed.
The SEM images indicated that the scaffolds maintained cellular adhesion, spread, and proliferation.
Such observation implies that the scaffolds well supported normal cell metabolism with favorable
biocompatibility in vitro.

12 SEM images from the cells attached to the surface of the specimens after 14 days of culture: (A) HA/MnO2
scaffold, (B) pure HA scaffold

CONCLUSION

HA powder was synthesized by sol‐gel method and modified with MnO2 deposition. Scaffolds were
then made using CIP method, followed by sintering at 1300°C. With the addition of MnO2 to HA, the
compressive strength increased by 6.5% and the toughness doubled. The samples also became denser
and the density increased by 4.95%. After immersion in the SBF solution, results of SEM images show
that the HA/MnO2 scaffold is rougher than the pure HA one. The results of cell attachment and
proliferation prove the biocompatibility of our HA/MnO2 bioscaffolds.
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